Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of antiviral and central nervous system drugs. Its structure supports high selectivity and binding affinity in biologically active molecules. Commonly employed in the preparation of protease inhibitors and receptor modulators due to the stability and stereochemical configuration provided by the trifluoromethyl group and hydroxymethyl substitution on the pyrrolidine ring.